Celldex Therapeutics
CLDX
$36.30
Share price
0.11%
Change (1 day)
15.46%
Change (1 year)
Categories
Celldex Therapeutics (CLDX) - Total debt
Total debt on the balance sheet as of December 2023 : $2.54 M
According to Celldex Therapeutics's latest financial reports the company's total debt is $2.54 M. A company’s total debt is the sum of all current and non-current debts.
Celldex Therapeutics - Total debt on balance sheet (from 2001 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $2.54 M | -36.97% |
| 2022-12-31 | $4.03 M | 32.58% |
| 2021-12-31 | $3.04 M | -12.61% |
| 2020-12-31 | $3.48 M | -4.81% |
| 2019-12-31 | $3.65 M | |
| 2018-12-31 | $N/A | -100% |
| 2017-12-31 | $6.56 M | |
| 2015-12-31 | $4.41 M | 70.45% |
| 2014-12-31 | $2.59 M | |
| 2013-12-31 | $N/A | -100% |
| 2012-12-31 | $11.33 M | -25.13% |
| 2011-12-31 | $15.14 M | 39.99% |
| 2010-12-31 | $10.81 M | -21.84% |
| 2009-12-31 | $13.84 M | 6248.62% |
| 2008-12-31 | $0.21 M | -95.78% |
| 2007-12-31 | $5.16 M | 11.32% |
| 2006-12-31 | $4.64 M | 122.41% |
| 2005-12-31 | $2.08 M | 1019.25% |
| 2004-12-31 | $0.18 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $70.84 B | 2,786,878.76% | 🇺🇸 USA |
 Amgen AMGN | $64.61 B | 2,541,717.47% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $22.93 B | 902,217.07% | 🇬🇧 UK |
 Titan Pharmaceuticals
TTNP | $0.56 M | -77.77% | 🇺🇸 USA |
 Seagen
SGEN | $0.11 B | 4,364.48% | 🇺🇸 USA |
 Agenus
AGEN | $78.01 M | 2,968.92% | 🇺🇸 USA |
 Emergent BioSolutions
EBS | $0.86 B | 33,739.50% | 🇺🇸 USA |